Godavari Biorefineries shares were listed on BSE today at Rs 310.55, a 12% discount from the issue price of Rs 352. On NSE, it was listed at Rs 308, a 12.5% discount from the issue price of Rs 352. .
Post-listing, the stock recovered some of its losses to close the session at Rs 342.85, up Rs 32.30 or 10.40% from its listing price.
The issue, which includes sale of fresh shares worth Rs 325 crore and offer for sale (OFS) of up to 6.53 million shares, was subscribed twice at the time of closing.
The company is one of the largest ethanol producers in India and has a biorefinery capacity of 570 KLPD for ethanol production. Our diverse portfolio includes bio-based chemicals, sugar, ethanol and power and is suitable for industries such as food, beverages, pharmaceuticals, personal care and fuels. In line with the government’s plan to increase ethanol blending, Godavari plans to expand its distillery capacity from 600 KLPD to 1,000 KLPD.
Godavari Biorefineries supplies products to leading companies including Hershey India, Hindustan Coca-Cola Beverages and LANXESS India. Financially, the company’s profit fell to Rs 12.3 crore for the fiscal year ending March 2024 from Rs 19.6 crore a year ago. Sales declined from Rs 2,014.7 crore to Rs 1,686.7 crore. In the June 2024 quarter, the company posted a loss of Rs 26.1 crore on revenue of Rs 522.5 crore. The IPO was managed by Equirus Capital and SBI Capital Markets, with Link Intime India acting as registrar.
According to data available with Trendlyne, she publicly holds 11 stocks with a net worth of over Rs 446.4 crore as of September 30, 2024. Her portfolio stocks include Unicommerce eSolutions, Samhi Hotels, Unicommerce eSolutions, Bombay Dyeing & Manufacturing Company, Kopran, Niyogin Fintech, Repro India, Rashi Peripherals, Sangam (India), IRIS Business Services, Transformers & Rectifiers (India) and Indostar Capital Finance. .
Also Read: At Rs 2.36 lakh, one Elcid share is worth more than Nvidia and FANG stocks combined
(Disclaimer: Recommendations, suggestions, views and opinions provided by experts are their own and do not represent the views of The Economic Times.)
